| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00073 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.00081 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00048 | 1 |